Torrent Pharmaceuticals share news, announcements and annual reports
NSE: TORNTPHARMBSE: 500420Pharmaceuticals & BiotechnologyLarge Cap
Share price at the NSE close on 28 Oct 2026. Previous close ₹4,625.00.
28 Oct: open ₹4,597.10, high ₹4,597.10, low ₹4,486.60
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,73,334 Cr61st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 81.61
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.43
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.83%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.76
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,26,21557.8% delivered
Torrent Pharmaceuticals analyst meets
90 filed, newest first. Page 1 of 2.
Oct 2026
9 Oct · Analysts
Sep 2026
10 Sep · Analysts
Aug 2026
11 Aug · Analysts
Jul 2026
17 Jul · Analysts
May 2026
30 May · Analysts
16 May · Analysts
12 May · Analysts
12 May · Analysts
Feb 2026
25 Feb · Analysts
11 Feb · Analysts
2 Feb · Analysts
Oct 2025
27 Oct · Analysts
Jul 2025
21 Jul · Analysts
Jun 2025
30 Jun · Analysts
May 2025
13 May · Analysts
Feb 2025
21 Feb · Analysts
14 Feb · Analysts
8 Feb · Analysts
7 Feb · Analysts
Jan 2025
15 Jan · Analysts
Oct 2024
14 Oct · Analysts
Sep 2024
24 Sep · Analysts
Jul 2024
18 Jul · Analysts
May 2024
10 May · Analysts
Feb 2024
16 Feb · Analysts
12 Feb · Analysts
6 Feb · Analysts
3 Feb · Analysts
Jan 2024
22 Jan · Analysts
9 Jan · Analysts
Oct 2023
Jul 2023
19 Jul · Analysts
May 2023
Feb 2023
18 Feb · Analysts
15 Feb · Analysts
Jan 2023
12 Jan · Analysts
Nov 2022
Oct 2022
Sep 2022
27 Sep · Analysts
Aug 2022
Jul 2022
May 2022
Jan 2022
11 Jan · Analysts
Nov 2021
29 Nov · Analysts
11 Nov · Analysts